nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of the Arbeitsgemeinschaft Internistische Onkologie with an integrated analysis of the ‘burden of therapy’ method
|
Haas, M. |
|
|
146 |
C |
p. 95-106 |
artikel |
2 |
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours
|
Vidal, Laura |
|
|
146 |
C |
p. 87-94 |
artikel |
3 |
A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma
|
Baart, Victor M. |
|
|
146 |
C |
p. 11-20 |
artikel |
4 |
Bromodomain and extra-terminal inhibitors—A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children—ACCELERATE
|
Pearson, Andrew DJ. |
|
|
146 |
C |
p. 115-124 |
artikel |
5 |
Changing trends in hepatocellular carcinoma management: Results from a nationwide database in the last decade
|
Cassinotto, Christophe |
|
|
146 |
C |
p. 48-55 |
artikel |
6 |
Clinical practice guidelines for B RCA1 and BRCA2 genetic testing
|
Pujol, Pascal |
|
|
146 |
C |
p. 30-47 |
artikel |
7 |
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms
|
Ambrosini, Valentina |
|
|
146 |
C |
p. 56-73 |
artikel |
8 |
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience
|
Bergeron, Christophe |
|
|
146 |
C |
p. 21-29 |
artikel |
9 |
Identification of laminin γ2 as a prognostic and predictive biomarker for determining response to gemcitabine-based therapy in pancreatic ductal adenocarcinoma
|
Okada, Yasuyuki |
|
|
146 |
C |
p. 125-134 |
artikel |
10 |
Immunotherapy-refractory, EGFR overexpressing metastatic porocarcinoma responding to cetuximab
|
Comito, Francesca |
|
|
146 |
C |
p. 84-86 |
artikel |
11 |
Long-term follow-up of blinatumomab in patients with relapsed/refractory Philadelphia chromosome–positive B-cell precursor acute lymphoblastic leukaemia: Final analysis of ALCANTARA study
|
Martinelli, Giovanni |
|
|
146 |
C |
p. 107-114 |
artikel |
12 |
Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx
|
Hoffmann, Caroline |
|
|
146 |
C |
p. 135-144 |
artikel |
13 |
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients
|
Malapelle, Umberto |
|
|
146 |
C |
p. 74-83 |
artikel |
14 |
Routine application of next-generation sequencing testing in uro-oncology—Are we ready for the next step of personalised medicine?
|
Rodler, Severin |
|
|
146 |
C |
p. 1-10 |
artikel |
15 |
Synaptophysin expression in V600EBRAF- mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis
|
Fassan, Matteo |
|
|
146 |
C |
p. 145-154 |
artikel |